|
Aradigm Receives Orphan Drug Designation For Inhaled Liposomal Ciprofloxacin To Treat Cystic Fibrosis In Europe
|
|
Scritto da Cystic Fibrosis News From Medical News Today |
|
Aradigm Corporation (OTCBB:ARDM) (the "Company") announced yesterday that the European Medicines Agency (EMEA) granted Orphan Drug Designation to the Company's inhaled liposomal ciprofloxacin drug product candidate for the treatment of lung infect ... ...
|
|
|
Genetic And Chromosomal Abnormalities In Embryos Detected By New Test
|
|
Scritto da Cystic Fibrosis News From Medical News Today |
|
One-step screening for both genetic and chromosomal abnormalities has come a stage closer as scientists announced that an embryo test they have been developing has successfully screened cells taken from spare embryos that were known to have cystic fi ... ...
|
|
Safe And Successful Fertility Treatment Possible In Women With Cystic Fibrosis
|
|
Scritto da Cystic Fibrosis News From Medical News Today |
|
Women with cystic fibrosis can have fertility treatment to help them have babies without any long-term adverse effects on either themselves or their children, according to new research presented at the 25th annual meeting of the European Society of H ... ...
|
|
Science Magazine Spotlights 20 Years Of CF Research
|
|
Scritto da Cystic Fibrosis News From Medical News Today |
|
An article in Science magazine this month highlights several promising new CF therapies, including VX-770 and VX-809 developed by Vertex Pharmaceuticals, as part of a look back at key moments in CF research since the discovery of the CF gene 20 years ... ...
|
|
|
Survival Of Patients With Idiopathic Pulmonary Fibrosis (IPF) Does Not Improve With Interferon Gamma-1b Treatment
|
|
Scritto da Cystic Fibrosis News From Medical News Today |
|
An article published Online First and in an upcoming edition of The Lancet reports the findings of the INSPIRE trial on treatment of idiopathic pulmonary fibrosis (IPF) with interferon gamma-1b (Ifn-g1b). It is written by Professor Talmadge E King Jr ... ...
|
|
Luminex Launches Two New Cystic Fibrosis Tests In Europe
|
|
Scritto da Cystic Fibrosis News From Medical News Today |
|
Luminex Corporation (NASDAQ: LMNX), the worldwide leader in multiplexed solutions, today announced that it has launched two new cystic fibrosis (CF) tests in Europe, the xTAG® Cystic Fibrosis 39 Kit v2 and xTAG® Cystic Fibrosis 71 Kit v2, as CE IVD M ... ...
|
|
|
Inizio Prec. 11 12 13 14 Succ. > Fine >>
|
| Pag 14 di 14 |
